KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 5, 2010, Pages 2278-2279

  Rhee, Ji Young ^a   Park, Young Kyoung ^b   Shin, Joo Yeon ^b   Choi, Ji Young ^b   Lee, Mi Young ^c   Peck, Kyong Ran ^b   Song, Jae Hoon ^b   Ko, Kwan Soo ^b  

^a Dankook University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; CARBAPENEMASE; COLISTIN; KLEBSIELLA PNEUMONIAE CARBAPENEMASE; MEROPENEM; METRONIDAZOLE; UNCLASSIFIED DRUG; VANCOMYCIN;

ACUTE HEART INFARCTION; AGED; ANGIOGRAPHY; ANTIBIOTIC SENSITIVITY; ARTIFICIAL VENTILATION; BACTERIAL GENE; BACTERIUM ISOLATE; BLOOD PRESSURE; BODY TEMPERATURE; BRONCHIAL ASPIRATION PROCEDURE; BROTH DILUTION; CASE REPORT; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DIARRHEA; ELECTROCARDIOGRAPHY; FEVER; GENOTYPE; GRAM STAINING; HEART VENTRICLE TACHYCARDIA; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; INOTROPISM; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; SEPSIS; SEPTIC SHOCK; SIGMOIDOSCOPY; SOUTH KOREA; TACHYPNEA; TERTIARY HEALTH CARE; THORAX PAIN; THORAX RADIOGRAPHY; VOMITING;

AGED; BETA-LACTAMASES; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY FAILURE, CHRONIC; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; RENAL DIALYSIS; REPUBLIC OF KOREA;

EID: 77951222934     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00011-10     Document Type: Letter

References (12)

1. Baraniak, A., R. Izdebski, M. Herda, J. Fiett, W. Hryniewicz, M. Gniadkowski, I. Kern-Zdanowicz, K. Filezak, and U. Łopaciuk. 2009. Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland. Antimicrob. Agents Chemother. 53:4565-4567.
2. Cardoso, O., A. F. Alves, and R. Leitão. 2008. Metallo-β- lactamase VIM-2 in Pseudomonas aeruginosa isolates from a cystic fibrosis patient. Int. J. Antimicrob. Agents 31:375-379.
3. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing: 18th informational supplement M100-S18. CLSI, Wayne, PA.
4. Diancourt, L., V. Passet, J. Verhoef, P. A. Grimont, and S. Brisse. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43:4178-4182.
5. KPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J. Antimicrob. Chemother. 63:427-437.
6. Giani, T., M. M. D'Andrea, P. Pecile, L. Borgianii, P. Nicoletti, F. Tonelli, A. Bartoloni, and G. M. Rossolini. 2009. Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 carbapenemase. J. Clin. Microbiol. 47:3793-3794.
7. Kim, J., Y. M. Lim, I. Rheem, Y. Lee, J. C. Lee, S. Y. Seol, Y. C. Lee, and D. T. Cho. 2005. CTX-M and SHV-12 β-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea. FEMS Microbiol. Lett. 245:93-98.
8. Kitchel, B., J. K. Rasheed, J. B. Patel, A. Srinivasan, S. Navon-Venezia, Y. Carmeli, A. Brolund, and C. G. Giske. 2009. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob. Agents Chemother. 53:3365-3370.
9. Nordmann, P., G. Cuzon, and T. Naas. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9:228-236.
10. Österblad, M., J. Kirveskari, S. Koskela, P. Tissari, K. Vuorenoja, A. J. Hakenen, M. Vaara, and J. Jalava. 2009. First isolations of KPC-2-carrying ST258 Klebsiella pneumoniae strains in Finland, June and August 2009. Euro Surveill. 14:1-2.
11. Paterson, D. L., and Y. Doi. 2007. A step closer to extreme drug resistance (XDR) in gram-negative bacilli. Clin. Infect. Dis. 45:1179-1181.
12. Yigit, H., A. M. Queenan, G. J. Anderson, A. Domenech-Sanchez, J. W. Biddle, C. D. Steward, S. Alberti, K. Bush, and F. C. Tenover. 2001. Novel carbapenems-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.